Does CARFILZOMIB Cause Nasopharyngitis? 132 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 132 reports of Nasopharyngitis have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.6% of all adverse event reports for CARFILZOMIB.
132
Reports of Nasopharyngitis with CARFILZOMIB
0.6%
of all CARFILZOMIB reports
9
Deaths
23
Hospitalizations
How Dangerous Is Nasopharyngitis From CARFILZOMIB?
Of the 132 reports, 9 (6.8%) resulted in death, 23 (17.4%) required hospitalization, and 3 (2.3%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for CARFILZOMIB.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which CARFILZOMIB Alternatives Have Lower Nasopharyngitis Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL